Annual costs associated with disease incidence and prevention in Colorado cow-calf herds participating in rounds 2 and 3 of the National Animal Health Monitoring System from 1986 to 1988

Thirty-nine and 47 randomly selected Colorado cow-calf operations were monitored for health events and their associated costs during rounds 2 and 3, respectively, of the National Animal Health Monitoring System (NAHMS). Data were collected from each operation for a one-year period by NAHMS veterinarians through monthly interviews, and the costs associated with the incidence and prevention of disease conditions were determined and expressed on a per cow basis. The beef producers involved in this study spent an average of $32.75 per cow in round 2 and $40.97 per cow in round 3 on an annual basis for the treatment of disease conditions. These costs were not different between the 2 rounds because of the wide ranges in the individual herd costs for disease incidence in each round. In both years of the study, the largest contributor to the total mean annual cost of disease incidence was the cost of death of diseased animals, and this cost accounted for approximately two-thirds of the total mean annual cost in each round. The total mean annual costs of disease prevention in these herds were $11.24 and $11.19 per cow in rounds 2 and 3, respectively. There were wide ranges in both rounds in the amounts of money spent per cow by individual herds for disease prevention. The largest individual cost of disease prevention in each year was the cost of vaccines/drugs, whereas the smallest individual cost in each round was the cost of veterinary services.(ABSTRACT TRUNCATED AT 250 WORDS)     

Expenditures for veterinary services and other costs of disease and disease prevention in 57 California beef herds in the National Animal Health Monitoring System (1988-1989)

Data on costs associated with episodes of disease and disease prevention, including expenditures for veterinary services, were collected from 57 California beef cow-calf herds during 1988-1989 as part of the National Animal Health Monitoring System. Mean cost associated with episodes of disease was $33.90/cow-year, with $0.78 and $1.37/cow-year being spent for veterinary services and drugs, respectively. The highest cost for veterinary services related to episodes of disease were for dystocia, lameness, and ocular carcinoma. For disease prevention, mean expenditures for veterinary services were $1.67/cow-year, nearly all of which was spent on prevention of reproductive tract conditions. Preventive expenditures for veterinary services related to female infertility (pregnancy examination), vaccination against brucellosis and male infertility (breeding soundness examination) were $0.72, $0.39, and $0.22/cow-year, respectively. Many costs associated with episodes of disease and disease prevention were similar to those reported from Colorado National Animal Health Monitoring System beef herds.     

Costs of veterinary services and vaccines/drugs used for prevention and treatment of diseases in 60 Tennessee cow-calf operations (1987-1988)

Four percent of the total cost of disease in 60 Tennessee cow-calf herds in 1987 to 1988 was attributable to veterinary services, and 2.3% was attributable to the purchase of drugs to treat sick animals. When producers spent money on therapeutic veterinary services, it was most often attributable to diseases of the reproductive system ($0.69/cow annually), especially dystocia ($0.51/cow annually). When drugs were used therapeutically, the most was spent on products to treat respiratory tract disease ($0.37/cow annually). The cost of preventive veterinary services accounted for 8.8% of the total cost of preventive actions. Pregnancy examinations (considered here as a preventive action) was the most costly preventive service ($0.62/cow annually). The cost of drugs and biologicals used to prevent disease accounted for 69.4% of the total cost of preventive actions, with drugs to prevent intestinal and external parasites being the most costly ($7.79/cow annually). These figures are based on cow-calf herds randomly selected by use of a 2-stage, stratified plan. Herds were visited once a month for 1 year. Results of this study support other work that showed that beef producers perceive veterinarians as primary sources of information on diagnosis and treatment of sick animals and on reproduction/breeding, but less knowledgeable or cost effective in the areas of animal/herd management, feed nutrition, and agribusiness/economics.     

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts

Nine dairy herds (mean size, 149 cows) with bulk-tank milk somatic cell counts of less than 300,000 cells/ml and greater than 80% of cows with Dairy Herd Improvement Association linear somatic cell counts less than or equal to 4 were selected for study. Each herd was monitored for 12 consecutive months. Duplicate quarter-milk specimens were collected from each cow for bacteriologic culturing at beginning of lactation, cessation of lactation, and at the time of each clinical episode of mastitis. Streptococcus agalactiae was never isolated and Staphylococcus aureus was isolated from less than 1% of all quarters. There were 554 episodes of clinical mastitis. During the year of study, the incidence rate of clinical mastitis varied from 15.6 to 63.7% of cows among the 9 herds. Mean costs per cow per year in herd for mastitis prevention were: $10 for paper towels, $3 for nonlactating cow treatment, and $10 for teat disinfectants. Mean cost associated with clinical mastitis was $107/episode. Approximately 84% ($90) of the costs attributed to a clinical episode were associated with decreased milk production and nonsalable milk. Costs of medication and professional veterinary fees per clinical episode varied significantly among the 9 herds. Three of the herds did not have a veterinarian treat a clinical episode of mastitis during the year of study even though 2 of these herds had the first and third highest incidence rates of clinical mastitis. When calculated on a per cow in herd basis, mean costs of $40/cow/year were attributed to clinical mastitis.(ABSTRACT TRUNCATED AT 250 WORDS)     

Veterinary and nonveterinary costs of disease in 29 California dairies participating in the National Animal Health Monitoring System from 1988 to 1989

Twenty-nine California dairy herds were studied over a 12-month period from 1988 to 1989 as part of the National Animal Health Monitoring System. Monthly interviews administered to dairy producers were used to measure the costs of all health-related expenditures and disease incidence in these herds. Of the total $1,523,558 reported, $1,355,467 (89%) was attributed to cost of disease events and $168,091 (11%) to cost of disease prevention. Most (78%) of the cost of disease events was attributable to death and culling losses. Veterinary services accounted for only $54,099 (4%) of total costs, 64% of which was used for disease prevention, compared with 36% for disease treatment. Udder disease was the most costly category of diseases reported at an average of $49.85/head at risk annually, followed by reproductive problems at $38.05. Through the use of sampling strategies less biased than those used in other surveys, the National Animal Health Monitoring System is designed to provide statistically-valid estimates of disease incidence and costs across broad geographic areas, potentially benefiting all those interested in the economics of livestock diseases in the United States.     

Direct production losses and treatment costs from bovine viral diarrhoea virus,bovine leukosis virus,Mycobacterium avium subspecies paratuberculosis,and Neospora caninum

Our purpose was to determine direct production losses (milk loss, premature voluntary culling and reduced slaughter value, mortaliy loss, and abortion and reproductive loss) and treatmetn costs (veterinary services, medication cost, and extra farm labour cost) due to four infectious diseases in the maritime provinces of Canada: bovine viral diarrhoea (BVD), enzootic bovine leukosis (EBL), Johne's Disease (JD), and neosporosis. We used a partial-budget model, and incorporated risk and sensitivity analyses to identify the effects of uncertainty on costs. Total annual costs for an average, infected, 50 cow herd were: JD$ 2472; BVD$ 2421; neosporosis $ 2304; EBL$ 806. The stochastic nature of the proportion of infected herds and prevalence of infection within a herd were used to estimate probability distributions for these ex post costs. For all diseases, these distributions were right skewed. A sensitivity analysis showed the largest effect on costs was due to milk yield effects. For example, changing milk production loss from 0 to 5% for BVD increased the costs for the disease by 266%.     

The cost of anaplasmosis in the Red River Plains and south-east areas of Louisiana

Losses from morbidity and mortality due to anaplasmosis were assessed in beef and dairy cattle of the Red River Plains and south-east areas of Louisiana. The cost of treatment and prevention of anaplasmosis and losses in milk production and those due to deaths or culling were valued at $0.5 million for the year 1983 in these two areas. The cost of prevention included the use of tetracyclines in feed and salt-mineral supplements, injectable tetracycline, vaccination and an estimated 10% of the cost of insecticidal ear tags, sprays, pour-on applications and dust bags. The remainder of these costs and the total cost of vector control in dairy cattle was attributed to the control of fly annoyance. Treatment costs included veterinary fees and the owner's treatment costs, including labour costs.     

Economic evaluation of Johne's disease control programs implemented on six Michigan dairy farms

Johne's disease (JD) is an incurable, chronic infectious disease prevalent in dairy herds throughout the US and the world. The substantial economic losses caused by JD have been well documented. However, information on the costs of controlling the disease is limited, yet necessary, if producers are to make sound decisions regarding JD management. The purpose of this paper is to describe a method for evaluating the cost-effectiveness of management changes to control JD on infected dairy farms. A 5-year longitudinal study of six dairy herds infected with JD was performed. Each herd implemented a JD control program upon study enrollment. Prevalence of JD within each herd was monitored with annual testing of all adult cows using fecal culture and/or serum ELISA. Individual cow production and culling information was collected to estimate the annual economic losses caused by JD. An economic questionnaire was developed and administered to each herd annually to estimate costs directly attributable to the JD control program. Based on the costs of the control program, and using the losses to estimate the potential benefits of the control program, the net present value (NPV) of the control program was calculated for each herd during the study and projected into the future for a total of 20 years. The NPV was calculated for four different scenarios: (1) assuming a linear decline in losses beyond the observed period of the study with JD eradication by year 20 of the control program; (2) assuming losses and JD prevalence remain constant at the rate equal to that of the last observed year while continuing the control program; (3) assuming linear increase in losses at rate equal to that in scenario 1 with no control program; and (4) assuming losses remain constant at same level as the beginning of the study with no control plan implemented. The NPV varied greatly across the herds. For scenario 1, only three herds had a positive NPV; and only two herds had a positive NPV under scenario two. In the absence of a control program, the NPV's were always negative. The costs of the JD control programs implemented on these herds averaged $30/cow/year with a median of $24/cow/year. The annual losses due to JD averaged $79/cow/year with a median of $66/cow/year. Investing in a JD control program can be cost-effective.     

Economic cost of difficult calvings in the United Kingdom dairy herd

Information on the losses associated with lower milk production and reproductive performance, as well as information from a survey of uk dairy herds using beef semen was used to estimate the economic importance of calving difficulties in uk dairy herds. The survey covered information on cow and calf mortality, cow culling and the need for veterinary assistance, the incidences of which were related to the degree of calving difficulty experienced. The total cost of a slightly difficult calving was estimated to be approximately 110 pounds, and of a seriously difficult calving between 350 pounds and 400 pounds, depending on assumptions of the veterinary costs. However, the major costs were associated with the labour required at the delivery, the increase in the number of days open, and the costs associated with the deaths of cows and calves, and cow culling.     

Vesicular stomatitis epidemic in colorado: Clinical observations and financial losses reported by dairymen

The financial impact and clinical expression of vesicular stomatitis in Colorado dairy herds was studied during the 1982 epidemic. A non-random sample of 15 dairy herds was surveyed, 13 of which had clinical cases in lactating cows. These 13 herds represented 2404 cows among which were 378 clinical cases. The dairymen reported a distribution of lesions among the cases as follows: 262 (69.3%) oral only; 87 (23.0%) teat only; 22 (5.8%) both oral and teat and 7 (1.9%) with foot lesions. Herds experiencing primarily oral lesions had an attack rate of 19.8% with an average clinical course of 23.8 days. The attack rate in 2 of the 4 herds with teat lesions was 55.8% and 1.6% in the other 2 herds. Mastitis complicated 72% of the cases with teat lesions.The direct costs resulting from 378 cases of vesticular stomatitis reported by 13 dairymen totaled $95 752, which is an average cost of $253.31 per clinical case. The average cost per case with oral lesions is estimated to be $174.06 in contrast to $568.22 average for cases with teat lesions. The greatest loss was due to cows culled, 36.6% of the total direct costs. Decreased milk production was second with 30.3% of the total.The average decrease in milk production per clinical case was 261.3 kg (576 lbs). Deaths accounted for 11.3% of the loss and the combined costs of drugs, extra labour, veterinary service, weight loss and extra ectoparasite control accounted for 11.9% of the $95 752 total.     

The incidence, cost and factors associated with foot lameness in dairy cattle in south-western Victoria

A survey of 73 dairy farms in south-western Victoria was conducted to assess the cost and mean herd incidence of foot lameness for the period from calving to the end of November, 1985, and to identify the herd, management and environmental factors associated with foot lameness. The mean herd size was 125 cows (range 82 to 220). Lameness occurred in 64 (88%) herds, and the mean herd incidence was 7.0% (range 0.0 to 30.9%). The main clinical signs associated with lameness were the presence of overworn and/or bruised soles, or stones lodged in the interdigital cleft. Factors associated with lameness were: property and herd size, age of cow, bail feeding, voluntary entry into the bails, and features of the farm track including its length, the presence of steep slopes, the type of surface material, presence and treatment of broken sections and maintenance including rolling history. The association of these factors with specific clinical signs was examined. The mean cost was estimated to be $42.90 per lame cow due to loss of production, treatment, the culling or death of lame cows, and extra man hours spent managing lame cows. It was concluded that the site, construction, maintenance and use of the farm track were of major importance to the incidence of lameness in herds in this area and recommendations for reducing lameness are made.     

The economic impact of clinical transmissible gastroenteritis for swine producers participating in the Missouri mail-in-record program

Economic loss from transmissible gastroenteritis (TGE) was estimated at $0.18 per hog marketed for the average Missouri Mail-in-Record swine panel producer in 1978. This cost was $0.19 per hog marketed in 1979. These estimates were averaged for all producers in the record system, those with TGE in their herds as well as TGE-free herds. Estimates were also prepared for those herds with TGE outbreaks. In 1978, the average loss due to TGE for producers who had the disease on their farms was estimated at $1.74 per hog marketed, or 18% of the average return earned above total production costs. In 1979, this cost was $1.25 per hog marketed, or 13% of the average return earned above total production costs.     

Association of herd productivity and bulk-tank somatic cell counts in US dairy herds in 1996

OBJECTIVE: To assess the association of bulk-tank somatic cell counts (BTSCC) and the value of herd productivity (milk produced, calves born, and net costs for cow replacements) in US dairy herds in 1996. DESIGN: Randomized stratified national survey of dairy producers. SAMPLE POPULATION: Records from 1,219 dairy herds in the top 20 dairy states. PROCEDURE: Responses for 1,178 herds had complete information for economic analysis. Per-cow value of production was determined for each herd. Data for herds with high (> or = 400,000 cells/ml) and medium (200,000 to 399,999 cells/ml) BTSCC were compared with values for herds with low BTSCC (< 200,000 cells/ml), using a multivariable regression model. RESULTS: In 1996, milk was priced at $0.287/kg ($13/cwt). Herds with low BTSCC annually generated $103.90/cow more in herd productivity than herds with medium BTSCC and $292.39/cow more than herds with high BTSCC. CONCLUSIONS AND CLINICAL RELEVANCE: Increased BTSCC (> 200,000 cells/ml) were associated with a reduced value of productivity per cow. Thus, dairy producers have a financial incentive to seek out and implement cost-effective management practices that will enable them to decrease their BTSCC to < 200,000 cells/ml and maximize herd productivity.     

Benefit-cost analysis of vaccination and preemptive slaughter as a means of eradicating foot-and-mouth disease

OBJECTIVE: To assess relative costs and benefits of vaccination and preemptive herd slaughter to control transmission of foot-and-mouth disease (FMD) virus (FMDV). SAMPLE POPULATION: 2,238 herds and 5 sale yards located in Fresno, Kings, and Tulare counties of California. PROCEDURE: Direct costs associated with indemnity, slaughter, cleaning and disinfecting livestock premises, and vaccination were compared for various eradication strategies. Additional cost, total program cost, net benefit, and benefit-cost value (B/C) for each supplemental strategy were estimated, based in part on results of published model simulations for FMD. Sensitivity analyses were conducted. RESULTS: Mean herd indemnity payments were estimated to be dollars 2.6 million and dollars 110,359 for dairy and nondairy herds, respectively. Cost to clean and disinfect livestock premises ranged from dollars 18,062 to dollars 60,205. Mean vaccination cost was dollars 2,960/herd. Total eradication cost ranged from dollars 61 million to dollars 551 million. All supplemental strategies involving use of vaccination were economically efficient (B/C range, 5.0 to 10.1) and feasible, whereas supplemental strategies involving use of slaughter programs were not economically efficient (B-C, 0.05 to 0.8) or feasible. CONCLUSIONS AND CLINICAL RELEVANCE: Vaccination with a highly efficacious vaccine may be a cost-effective strategy for control of FMD if vaccinated animals are not subsequently slaughtered and there is no future adverse economic impact, such as trade restrictions. Although less preferable than the baseline eradication program, selective slaughter of highest-risk herds was preferable to other preemptive slaughter strategies. However, indirect costs can be expected to contribute substantially more than direct costs to the total cost of eradication programs.     

Estimate of the annual economic impact of treatment of cranial cruciate ligament injury in dogs in the United States

OBJECTIVE: To estimate the economic impact to veterinary clients for the medical and surgical treatment of rupture of the cranial cruciate ligament (RCCL) in dogs for the year 2003. DESIGN: Economic impact survey. SAMPLE POPULATION: 501 diplomates of the American College of Veterinary Surgeons (ACVS) indicating that their area of surgical emphasis was small animal orthopedic surgery or small animal general and orthopedic surgery and 4,000 veterinarians indicating to the AVMA that their professional area was small animal practice exclusive or mixed animal practice (at least 80% small animal). PROCEDURE: Veterinarians were surveyed concerning the cost for medical and surgical treatment of RCCL for 2003. The economic impact was calculated by multiplying the number of RCCL surgeries performed by the mean cost of surgery. This was added to the number of RCCL cases managed medically multiplied by the mean cost of medical management. This estimate for survey responders was extrapolated to the total number of veterinarians in the study population for the ACVS or AVMA. RESULTS: Estimates for the total cost of surgery were $171,730,134.72 and $1,020,167,907 for veterinarians in the ACVS and AVMA populations, respectively. The cost of medical management was $2,885,687.86 and $126,558,155.16 for veterinarians in the ACVS and AVMA populations, respectively. After combining the ACVS and AVMA populations, we estimated that owners spent $1.32 billion for the treatment of RCCL in the United States in 2003. CONCLUSIONS AND CLINICAL RELEVANCE: RCCL is a prevalent, costly injury. Results may motivate veterinary and consumer agencies to prioritize funding for a better understanding of the injury.     

奶牛乳房炎的防治

奶牛乳房炎是一种常见病和多发病,是目前严重危害和困扰奶牛养殖业及产奶业最常见的疾病之一,此病的发生不仅严重地影响了奶牛产奶量和奶质,而且还会造成奶牛使用年限减少,淘汰提前,饲料汇报率降低,治疗和管理成本增加,乳中兽药和抗生素残留,危及人类健康和环境安全等巨大经济损失,直接影响着养殖业的经济收入。为了减少该病的发生,提高乳质量,对我场奶牛进行了奶牛乳房炎的发病规律和治疗情况的调查,并且提出相应的防治措施,有效的控制了乳房炎的发生。     

Epidemiological aspects and financial impact of lumpy skin disease in Ethiopia

The financial cost of clinical Lumpy Skin Disease (LSD) and the financial benefit of its control through vaccination were studied based on questionnaire survey in Oromia region of Ethiopia from the perspective of livestock farmers. Production loss impacts for local zebu cattle were compared with those of Holstein Friesian (HF)/crossbred cattle in the study area. Annual cumulative incidence of LSD infection in HF/crossbred and local zebu cattle were 33.93% (95% CI: 30.92-36.94) and 13.41% (95% CI: 12.6-14.25) respectively and significantly different (p<0.05). Annual mortality was also significantly higher in HF/crossbred 7.43% (95% CI: 5.76-9.10) than in local zebu cattle 1.25% (95% CI: 0.98-1.52). The annual financial cost was calculated as the sum of the average production losses due to morbidity and mortality arising from milk loss, beef loss, traction power loss, and treatment and vaccination costs at the herd level. The financial cost in infected herds was estimated to be USD 6.43 (5.12-8) per head for local zebu and USD 58 (42-73) per head for HF/crossbred cattle. A partial budget analysis was used to estimate the financial benefit of an annual vaccination program in both the local zebu and HF/crossbred cattle farming systems. The marginal rate of return (MRR) gained from this control intervention was estimated to be 34 (3400%) and the net benefit per head was USD 1 for local zebu and USD 19 for HF/crossbred cattle. Vaccination thus enabled financial costs due to LSD to be reduced by 17% per head in local zebu herds and 31% per head in HF/crossbred herds. These results could provide guidance to producers and the government in their endeavors to control the disease.     

Socioeconomic burden of severe fever with thrombocytopenia syndrome in endemic areas of Anhui Province,eastern China

Understanding the socioeconomic burden of severe fever with thrombocytopenia syndrome (SFTS) is important for making decisions on health resources allocation. This study aimed to assess the economic burden of patients with this syndrome in endemic areas of the Anhui Province in 2018. A total of 114 patients were recruited, and the median age was 63.5 years, 62 (54.4%) were female, 97 (85.1%) were farmers, 108 (94.7%) were survival patients, and 71 (62.3%) had a family monthly income less than $453.3. The median times of hospital visits and hospitalizations of patients were three times, and the median lost work days of these patients, caregivers and visitors were 14.5 days, 14.5 days and 7.5 days, respectively. The median direct costs of the patient were $3,761.6, and the median indirect costs were $508.3. Taking direct and indirect costs into consideration, the median total economic costs of patients were $4,323.9, and the total annual cost of 2018 was $1,396,913.6. Although 113 (99.1%) patients had medical insurance, only 25.8% of costs were covered by reimbursement, and the total cost paid for by the patients and their families was $1,041,073.6 in 2018. Our findings revealed that the patients and their families had a significant economic burden, and preventive measures should be strengthened in endemic areas. The findings also provided baseline data for assessing the cost‐effectiveness of the vaccines or anti‐viral drugs in the near future in China.     

A Retrospective Economic Analysis of the Ontario Red Fox Oral Rabies Vaccination Programme

Ontario initiated a red fox (Vulpes vulpes ) oral rabies vaccination (ORV) programme in 1989. This study utilized a benefit‐cost analysis to determine if this ORV programme was economically worthwhile. Between 1979 and 1989, prior to ORV baiting, the average annual human post‐exposure treatments, positive red fox rabies diagnostic tests and indemnity payments for livestock lost to rabies were 2248, 1861 and $246 809, respectively. After baiting, from 1990 to 2000, a 35%, 66% and 41% decrease in post‐exposure treatments, animal rabies tests and indemnity payments was observed, respectively. These reductions were viewed as benefits of the ORV programme, whereas total costs were those associated with ORV baiting. Multiple techniques were used to estimate four different benefit streams and the total estimated benefits ranged from $35 486 316 to $98 413 217. The annual mean ORV programme cost was $6 447 720, with total programme costs of $77 372 637. The average benefit‐cost ratios over the analysis period were .49, 1.06, 1.27 and 1.36, indicating overall programme efficiency in three of the four conservative scenarios.     

Estimation of the costs of mastitis, using National Animal Health Monitoring System and milk somatic cell count data

Data collected by the National Animal Health Monitoring System in Ohio for a 12-month period during 1986 and 1987 were used to determine the relative magnitude of costs associated with mastitis in the following categories: milk production loss, veterinary services, drugs, producer labor, and "other" factors. The cost of milk loss associated with mastitis that was reported by producers cooperating in the National Animal Health Monitoring System program was compared with estimates based on bulk tank somatic cell counts and individual cow milk somatic cell counts. Using producer-reported estimates, milk loss accounted for about one third of the total cost associated with mastitis. When estimates of milk loss were replaced by estimates based on bulk tank somatic cell counts, milk loss accounted for over 80% of the total cost of mastitis. Estimates of the cost of milk loss based on studies relating milk yield to somatic cell counts differed considerably. Consequently, it was unclear how to best estimate the relative magnitude of the milk loss component of mastitis costs.